MEREDITH RAY

Allopathic & Osteopathic Physicians|Family Medicine FEASTERVILLE TREVOSE, PA NPI 1497723944

General Payments — all program years on this page

$1,041.73

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 70
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $310.67 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $310.6717

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $249.1723
2019 $177.9311
2020 $58.644
2022 $73.614
2023 $171.7111
2024 $310.6717

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097221296 Novo Nordisk Inc $18.70 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104216255 AstraZeneca Pharmaceuticals LP $13.49 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104474528 AstraZeneca Pharmaceuticals LP $13.62 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104611570 AstraZeneca Pharmaceuticals LP $24.45 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105409748 AstraZeneca Pharmaceuticals LP $13.78 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105597637 AstraZeneca Pharmaceuticals LP $13.62 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105725435 AstraZeneca Pharmaceuticals LP $14.38 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114848986 Exact Sciences Corporation $23.00 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114848991 Exact Sciences Corporation $18.75 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116665071 GlaxoSmithKline, LLC. $19.40 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118033425 Boehringer Ingelheim Pharmaceuticals, Inc. $24.76 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131793875 PFIZER INC. $14.67 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131900595 PFIZER INC. $18.61 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135189353 Lilly USA, LLC $14.60 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135213241 Lilly USA, LLC $13.49 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139420991 Astellas Pharma US Inc $24.41 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142181336 Optinose US, Inc. $26.94 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.